The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Stock and Other Ownership Interests - Auron Therapeutics
Consulting or Advisory Role - Agios; Amgen; Astellas Pharma; Bristol-Myers Squibb; Daiichi Sankyo; Genentech; Novartis; Syros Pharmaceuticals
Research Funding - Agios (Inst); Amgen (Inst); Bayer (Inst); BioTheryX (Inst); Bristol-Myers Squibb (Inst); Syndax (Inst)
 
Consulting or Advisory Role - Abbvie; Agios; Bayer; Bristol-Myers Squibb; Daiichi Sankyo; FORMA Therapeutics; Janssen; Novartis; Pfizer; Pierre Fabre; Seagen; SERVIER; Syros Pharmaceuticals
Speakers' Bureau - Abbvie; Bristol-Myers Squibb; Janssen
Research Funding - Agios (Inst)
Travel, Accommodations, Expenses - Agios; Bristol-Myers Squibb; Daiichi Sankyo; FORMA Therapeutics; Novartis; Pfizer; Seagen; Syros Pharmaceuticals
Effect of enasidenib (ENA) plus azacitidine (AZA) on complete remission and overall response versus AZA monotherapy in mutant-IDH2 (mIDH2) newly diagnosed acute myeloid leukemia (ND-AML).
 
Courtney Denton Dinardo
Leadership - Notable Labs
Honoraria - Abbvie; Agios; Celgene; Daiichi Sankyo; Jazz Pharmaceuticals; MedImmune; Syros Pharmaceuticals
Consulting or Advisory Role - Abbvie; Agios; Celgene
Research Funding - Abbvie; AGIOS; Celgene; Daiichi Sankyo
 
Andre C. Schuh
Honoraria - Amgen; Astellas Pharma; Bristol-Myers Squibb
Consulting or Advisory Role - Amgen; Astellas Pharma; Bristol-Myers Squibb; Jazz Pharmaceuticals
Travel, Accommodations, Expenses - Agios; Amgen; Bristol-Myers Squibb; Jazz Pharmaceuticals
 
Eytan M. Stein
No Relationships to Disclose
 
Pau Montesinos
Consulting or Advisory Role - Abbvie; Celgene; Daiichi Sankyo; Jazz Pharmaceuticals; Novartis; Pfizer; Roche; Shire
Speakers' Bureau - Celgene; Daiichi Sankyo; Otsuka
Research Funding - Celgene (Inst); Janssen-Cilag (Inst); Pfizer (Inst)
Travel, Accommodations, Expenses - Amgen
 
Andrew Wei
Honoraria - Abbvie/Genentech; Amgen; Celgene; Janssen Oncology; Novartis; Pfizer; Roche; SERVIER
Consulting or Advisory Role - Abbvie/Genentech; Amgen; Celgene; Macrogenics; Novartis; Pfizer; SERVIER
Speakers' Bureau - Abbvie/Genentech; Amgen; Celgene; Novartis
Research Funding - Abbvie (Inst); AstraZeneca (Inst); Celgene (Inst); Novartis (Inst); Servier (Inst)
Patents, Royalties, Other Intellectual Property - AW is a former employee of the Walter and Eliza Hall Institute which receives milestone and royalty payments related to venetoclax, and is eligible for benefits related to these payments. AW receives payments from WEHI related to venetoclax
Travel, Accommodations, Expenses - Abbvie; Amgen; Celgene; Janssen Oncology; Novartis; Pfizer; Servier
 
Stephane De Botton
No Relationships to Disclose
 
Amer Methqal Zeidan
Honoraria - Abbvie; Acceleron Pharma; Agios; Astellas Pharma; BeyondSpring Pharmaceuticals; Boehringer Ingelheim; Bristol-Myers Squibb; Cardinal Health; Celgene; Daiichi Sankyo; Epizyme; Incyte; Ions Pharmaceuticals; Jazz Pharmaceuticals; Novartis; Otsuka; Pfizer; Seagen; Taiho Pharmaceutical; Takeda; Trovagene
Consulting or Advisory Role - Abbvie; Acceleron Pharma; Agios; Astellas Pharma; BeyondSpring Pharmaceuticals; Boehringer Ingelheim; Bristol-Myers Squibb; Cardinal Health; Celgene; Daiichi Sankyo; Epizyme; Incyte; Ions Pharmaceuticals; Jazz Pharmaceuticals; Novartis; Otsuka; Pfizer; Seagen; Taiho Pharmaceutical; Takeda; Trovagene
Research Funding - Abbvie (Inst); ADC Therapeutics (Inst); Aprea AB (Inst); Astex Pharmaceuticals (Inst); AstraZeneca/MedImmune (Inst); Boehringer Ingelheim (Inst); Bristol-Myers Squibb (Inst); Celgene (Inst); Incyte (Inst); Novartis (Inst); Pfizer (Inst); Takeda (Inst); Trovagene (Inst)
Travel, Accommodations, Expenses - Celgene; Novartis; Pfizer; Trovagene
 
Amir Tahmasb Fathi
Honoraria - DAVA Pharmaceuticals
Consulting or Advisory Role - Agios; Astellas Pharma; Boston Biomedical; Celgene; Clear Creek Bio; Daiichi Sankyo; Jazz Pharmaceuticals; Newlink Genetics; Novartis; PTC Therapeutics; Takeda
Research Funding - agios (Inst); Celgene (Inst); Exelixis (Inst); Seagen (Inst); Takeda (Inst)
 
Lynn Quek
Speakers' Bureau - Bristol-Myers Squibb
Research Funding - Agios (Inst); Bristol-Myers Squibb (Inst)
 
Hagop M. Kantarjian
Honoraria - Abbvie; Actinium Pharmaceuticals; Agios; Amgen; ARIAD; Bristol-Myers Squibb; Immunogen; Orsenix; Pfizer; Takeda
Research Funding - Abbvie (Inst); Agios (Inst); Agios (Inst); Agios (Inst); Amgen (Inst); ARIAD (Inst); Astex Pharmaceuticals (Inst); Bristol-Myers Squibb (Inst); Cyclacel (Inst); Immunogen (Inst); Jazz Pharmaceuticals (Inst); Novartis (Inst); Pfizer (Inst); Pfizer (Inst)
 
Mark G. Frattini
Employment - Bristol-Myers Squibb
Stock and Other Ownership Interests - Bristol-Myers Squibb
 
Frederik Lersch
Employment - Bristol-Myers Squibb
Stock and Other Ownership Interests - Bristol-Myers Squibb
 
Jing Gong
Employment - Celgene
Stock and Other Ownership Interests - Celgene
 
Aleksandra Franovic
Employment - Bristol-Myers Squibb
Stock and Other Ownership Interests - Bristol-Myers Squibb
 
Paresh Vyas
Stock and Other Ownership Interests - OxStem
Honoraria - Abbvie; Celgene; Daiichi Sankyo; Jazz Pharmaceuticals; Pfizer
Research Funding - Celgene; Forty Seven
Patents, Royalties, Other Intellectual Property - Patent for flow cytometric detection of leukaemic stem cells
 
Hartmut Dohner
Honoraria - Abbvie; Celgene; Jazz Pharmaceuticals; Novartis
Consulting or Advisory Role - Abbvie; Agios; Amgen; Astellas Pharma; Astex Pharmaceuticals; Celgene; Jazz Pharmaceuticals; Roche
Research Funding - Amgen (Inst); Arog (Inst); Bristol-Myers Squibb (Inst); Jazz Pharmaceuticals (Inst); Novartis (Inst); Pfizer (Inst); Sunesis Pharmaceuticals (Inst)